Table 2 Univariate logistic regression analysis of baseline factors related to relapse
From: Efficacy of early immunomodulator therapy on the outcomes of Crohn’s disease
Valuables | OR (95% CI) | P-value | |
|---|---|---|---|
Age | 0.999 (0.967-1.032) | 0.940 | |
Gender | Male | ||
Female | 0.769 (0.337-1.754) | 0.533 | |
BMI | 0.980 (0.866-1.109) | 0.748 | |
CDAI severity | Mild | ||
Moderate | 1.957 (0.186-20.614) | 0.576 | |
Severe | 2.203 (0.222-21.849) | 0.500 | |
ESR* | > 15 mm/hr | 0.745 (0.321-1.727) | 0.492 |
CRP† | > 8.0 mg/L | 3.000 (1.504-5.983) | 0.002 |
Hct‡ | > 40.4% | 1.203 (0.622-2.329) | 0.583 |